Wyndly
Wyndly, previously known as Wyndly Health, is a healthcare company based in New York offering personalized sublingual immunotherapy (SLIT) treatment plans for allergy relief, supported by telehealth services.
Services
Wyndly specializes in providing personalized immunotherapy treatment plans for allergy relief. Their approach utilizes sublingual immunotherapy (SLIT), which is delivered via at-home allergy testing to identify specific triggers. Treatment plans include unlimited doctor support and free shipping. The company also offers an Allergy-Free Guarantee, which is a 90-Day 100% Money-Back Promise. The subscription model costs $99/month if paid annually, or $110/month if paid quarterly. Allergy tests can be billed through insurance, and HSA and FSA insurance are accepted.
Founders
Wyndly was founded by Dr. Manan Shah and Aakash Shah. Together, they have guided the company to provide personalized, convenient allergy treatment solutions. Their expertise drives the company's telehealth model, which provides patients with tailored treatment plans based on specific allergy triggers.
Products
Wyndly offers an at-home allergy test kit that measures sensitivity to 40 common indoor and outdoor allergens. The company's treatment plans, which are based on the results of these tests, have an 85% success rate and aim to provide lifelong relief from allergies. The at-home delivery model includes free shipping for all treatments, making it a more affordable option compared to traditional in-office care.
Industry
Wyndly operates in the healthcare sector, specifically within the consumer health and wellness sub-industry. The company is part of Y Combinator's W21 batch and is backed by a group of angel investors and venture capitalists. Wyndly serves customers across the United States with a fully remote model, offering accessible allergy treatment.
History
Wyndly, formerly known as Wyndly Health, is based in New York, NY, and also operates remotely. The company has a team of 8 and was founded by Dr. Manan Shah and Aakash Shah. Since its inception, Wyndly has focused on providing personalized allergy treatment through telehealth visits and sublingual immunotherapy. The company has garnered support from Y Combinator and other investors, helping it grow and offer its services nationwide.
